Effect of Quercetin on the Anti-tumor Activity of Cisplatin in EMT6 Breast Tumor-bearing Mice

Overview

Journal Obstet Gynecol Sci

Specialty Gynecology & Obstetrics

Date 2019 Jul 25

PMID 31338341

Citations 17

Authors

Hyunju Liu

Jung In Lee

Tae-Gyu Ahn

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this study was to determine the effect of quercetin on the antitumor activity of cisplatin and its side-effects.

Methods: EMT6 cells, a mouse breast cancer cell line, were injected subcutaneously in mice to generate a breast tumor-bearing mouse model. Experimental groups were divided into four groups: control (C), quercetin (Q), cisplatin (CP), and cisplatin+quercetin (CP+Q).

Results: The tumor volume of the CP+Q group was significantly lower than that of the CP group. Serum blood urea nitrogen and creatinine levels in the CP+Q group were lower than those in the CP group. Renal γ-glutamyltranspeptidase and alkaline phosphatase activities were significantly higher in the CP+Q group than in the CP group, and the content of renal thiobarbituric acid reactive substance was significantly lower in the CP+Q group than that in the CP group. These results suggested that quercetin and cisplatin synergistically increased cellular toxicity in breast cancer cells and mediated cancer growth inhibition, thereby enhancing the antitumor effect of cisplatin compared to when only cisplatin was administered. Quercetin also reduced renal toxicity, which arose as a potential a side effect of cisplatin.

Conclusion: The enhanced antitumor effect of cisplatin and decreased renal toxicity after quercetin treatment suggested the applicability of quercetin as an adjuvant for chemotherapeutic agents.

Citing Articles

From nature to clinic: Quercetin's role in breast cancer immunomodulation.

Fang L, Gao D, Wang T, Zhao H, Zhang Y, Wang S Front Immunol. 2024; 15:1483459.

PMID: 39712006 PMC: 11659267. DOI: 10.3389/fimmu.2024.1483459.

Anticancer Activity and Molecular Mechanisms of Acetylated and Methylated Quercetin in Human Breast Cancer Cells.

Sakao K, Hamamoto S, Urakawa D, He Z, Hou D Molecules. 2024; 29(10).

PMID: 38792269 PMC: 11124128. DOI: 10.3390/molecules29102408.

A Natural Organic Compound "Decursin" Has Both Antitumor and Renal Protective Effects: Treatment for Osteosarcoma.

Hayashi D, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Mori Y J Oncol. 2023; 2023:5445802.

PMID: 38130464 PMC: 10735716. DOI: 10.1155/2023/5445802.

Recent Advances in Potential Health Benefits of Quercetin.

Aghababaei F, Hadidi M Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513932 PMC: 10384403. DOI: 10.3390/ph16071020.

Insights on the Role of Polyphenols in Combating Cancer Drug Resistance.

Farhan M Biomedicines. 2023; 11(6).

PMID: 37371804 PMC: 10296548. DOI: 10.3390/biomedicines11061709.

References

Fatima S, Arivarasu N, Mahmood R . Vitamin C attenuates cisplatin-induced alterations in renal brush border membrane enzymes and phosphate transport. Hum Exp Toxicol. 2007; 26(5):419-26. DOI: 10.1177/0960327106072389. View

Sanchez-Gonzalez P, Lopez-Hernandez F, Duenas M, Prieto M, Sanchez-Lopez E, Thomale J . Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues. Food Chem Toxicol. 2017; 107(Pt A):226-236. DOI: 10.1016/j.fct.2017.06.047. View

Mishra B, Tiwari V . Natural products: an evolving role in future drug discovery. Eur J Med Chem. 2011; 46(10):4769-807. DOI: 10.1016/j.ejmech.2011.07.057. View

Matsuyama R, Reddy S, Smith T . Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol. 2006; 24(21):3490-6. DOI: 10.1200/JCO.2005.03.6236. View

Khan F, Niaz K, Maqbool F, Hassan F, Abdollahi M, Nagulapalli Venkata K . Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update. Nutrients. 2016; 8(9). PMC: 5037516. DOI: 10.3390/nu8090529. View

Sharp C, Siskind L . Developing better mouse models to study cisplatin-induced kidney injury. Am J Physiol Renal Physiol. 2017; 313(4):F835-F841. PMC: 5668582. DOI: 10.1152/ajprenal.00285.2017. View

Jordan P, Carmo-Fonseca M . Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci. 2000; 57(8-9):1229-35. PMC: 11147023. DOI: 10.1007/pl00000762. View

Tate S, Meister A . gamma-Glutamyl transpeptidase from kidney. Methods Enzymol. 1985; 113:400-19. DOI: 10.1016/s0076-6879(85)13053-3. View

Aghapour F, Moghadamnia A, Nicolini A, Mousavi Kani S, Barari L, Morakabati P . Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochem Biophys Res Commun. 2018; 500(4):860-865. DOI: 10.1016/j.bbrc.2018.04.174. View

10.

Hill J, Loeb E, MacLellan A, HILL N, Khan A, King J . Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases. Cancer Chemother Rep. 1975; 59(3):647-59. View

11.

Lonning P . Molecular basis for therapy resistance. Mol Oncol. 2010; 4(3):284-300. PMC: 5527935. DOI: 10.1016/j.molonc.2010.04.005. View

12.

Chuthapisith S, Eremin J, El-Sheemy M, Eremin O . Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy. Surgeon. 2006; 4(4):211-9. DOI: 10.1016/s1479-666x(06)80062-4. View

13.

Kandaswami C, Kanadaswami C, Lee L, Lee P, Hwang J, Ke F . The antitumor activities of flavonoids. In Vivo. 2005; 19(5):895-909. View

14.

Hartmann J, Lipp H . Toxicity of platinum compounds. Expert Opin Pharmacother. 2003; 4(6):889-901. DOI: 10.1517/14656566.4.6.889. View

15.

Li Q, Liang Y, Hu G, Tian Y . Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats. Indian J Pharmacol. 2016; 48(2):168-71. PMC: 4825434. DOI: 10.4103/0253-7613.178834. View

16.

Tenenhouse H, Scriver C, Vizel E . Alkaline phosphatase activity does not mediate phosphate transport in the renal-cortical brush-border membrane. Biochem J. 1980; 190(2):473-6. PMC: 1162116. DOI: 10.1042/bj1900473. View

17.

Vogl D, Stadtmauer E . High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed. Bone Marrow Transplant. 2006; 37(11):985-7. DOI: 10.1038/sj.bmt.1705366. View

18.

Zhang X, Guo Q, Chen J, Chen Z . Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis. Mol Cells. 2015; 38(7):638-42. PMC: 4507030. DOI: 10.14348/molcells.2015.0037. View

19.

Arzuman L, Beale P, Chan C, Yu J, Huq F . Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines. Anticancer Res. 2014; 34(10):5453-64. View

20.

Behling E, Sendao M, Francescato H, Antunes L, Costa R, Bianchi M . Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep. 2006; 58(4):526-32. View